DefinitionThis section has been translated automatically.
Mucolytic, expectorant.
Half-lifeThis section has been translated automatically.
3,5 h
You might also be interested in
Pharmacodynamics (Effect)This section has been translated automatically.
Secretolytic, stimulation of surfactant synthesis in type II pneumocytes, antioxidant.
IndicationThis section has been translated automatically.
Expectoration promotion in acute and chronic bronchopulmonary diseases.
Limited indicationThis section has been translated automatically.
Pregnancy, lactation, gastric ulcer, renal insufficiency.
Dosage and method of useThis section has been translated automatically.
- Adults and adolescents > 14 years: 16-20 mg 3 times/day or 12 mg 4 times/day p.o. or i.v. (total daily dose 24-48 mg).
- Children 6-14 years and patients < 50 kg bw: 3 times/day 8 mg p.o. or i.v.
- Children < 6 years. 3 times/day 4 mg p.o. or i.v.
Undesirable effectsThis section has been translated automatically.
Allergic reactions up to anaphylactic shock, dyspnoea, chesty cough, gastrointestinal disturbances, increases in transaminases.
ContraindicationThis section has been translated automatically.
Paragroup allergy (some liquid preparations), hypersensitivity to the active substance.
PreparationsThis section has been translated automatically.
Aparsonine, Bisolvon, Bromhexine, Omniapharm
Prof. Dr. med. Peter Altmeyer